Press releases

Month Year

Email alerts

Apr 23, 2018

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm

DUBLIN - April 23, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon (DCB)...
Apr 17, 2018

Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres

Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors

DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...
Apr 10, 2018

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
Apr 9, 2018

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure

DUBLIN - April 9, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the...
Apr 9, 2018

Medtronic to Unveil Additional Clinical Data on HVAD® System at ISHLT 2018

Data on Implant Approach, Blood Pressure Management, Length of Stay, and Quality of Life to be Featured During Congress.

DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT) today announced a preview of notable clinical data on the HeartWare HVAD® System that will be presented at The International Society of Heart...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa